Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


EAGLE PHARMACT   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period202020192018201720162015201420132012
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/20159/30/20149/30/20139/30/2012
Product sales72.3273.9970.3945.3340.6512.974.635.321.16
Royalty income110.48112.90142.93153.8899.048.2610.718.361.38
Other income5.009.00--37.5049.8045.003.77----
Total Revenue187.80195.89213.31236.71189.4866.2319.1013.682.54
Cost of product sales33.6547.8942.3733.7135.797.76------
Cost of Revenue----------7.895.047.383.17
Cost of royalty11.8213.0119.5423.4719.52--6.67----
Research and development30.7936.8144.4232.6128.2927.8616.829.8012.81
Selling, general and administrative78.6076.3760.5171.4253.3320.179.334.966.40
Restructuring charge0.000.007.910.00----------
Legal settlement------(1.65)----------
Asset impairment charges----(2.70)(7.24)----------
Gain on sale of asset--------1.75--------
Changes in fair value of contingent consideration----0.767.38(0.96)--------
Total Operating Expenses154.85174.08176.70162.72136.1363.6737.8622.1322.37
Income (Loss) from operations32.9521.8236.6273.9953.352.56(18.76)(8.46)(19.83)
Interest expense2.582.692.741.140.010.010.010.310.09
Net proceeds from arbitration--------------(4.05)--
Interest income0.562.170.160.090.080.030.030.000.03
Other income/(expense), net(8.26)0.70--------0.040.000.01
Deferred financing costs--------------(0.10)(0.02)
Amortization of debt discount--------------(1.09)(0.22)
Change in value of warrant liability------------(0.57)(1.05)--
Loss on subscription loan settlement----------------(0.05)
Total other income/(expense), net(10.28)0.18(2.58)(1.05)0.080.01(0.52)1.51(0.33)
Income (loss) before income tax22.6822.0034.0472.9553.432.57(19.27)(6.95)(20.16)
Income tax (benefit) expenses10.697.692.1421.00(28.03)0.00(1.30)(0.90)(0.78)
Net Income (loss)------51.94----(17.98)(6.05)(19.38)
Dividends on Series A, B, B-1 and C Convertible Preferred Stock------------1.673.843.93
Net income (loss) attributable to common stockholders11.9914.3131.9051.9481.452.57(19.64)(9.89)(23.32)
Income (Loss) per share attributable to common stockholders Basic0.891.042.163.445.240.17(1.97)(3.25)(14.11)
Income (Loss) per share attributable to common stockholders Diluted0.871.012.093.274.960.16(1.97)(3.25)(14.11)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING BASIC13.4813.7614.7715.1015.5315.259.963.041.65
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING DILUTED13.7714.1415.2815.9116.4316.259.963.041.65